GENEART Receives European Patent for Screening Process for Antiviral Therapeutics
News Feb 06, 2009
GENEART AG informs of being awarded patent EP 1 356 111 "Kernexportreportersystem" ("Nucleus Export Reporter System") by the European patent office.
The patent describes a new screening system based on synthesized virus-like reporter genes with which a new class of antiviral drug candidates may be identified. Thus allowing to analyze by high-throughput processes to which extent such drug candidates block the export of viral messenger RNA from the cell nucleus and therefore suppress virus propagation.
Additionally, this process may be used for identification of DNA motives positively affecting production rates of cell factories and therefore production costs of proteins. The patent covers Austria, Switzerland, Spain, Liechtenstein, France, the United Kingdom, Luxemburg, the Netherlands, Sweden, Belgium, Italy and Germany.
The German patent of this family of patents had been granted as early as 2008. An application for a comparable protection for North America has been filed under the international patent process.
"With being granted the European patent, we did not only protect a process with which new antiviral active agents can be identified based on optimized genes, now we also have another proprietary technology available, beside our gene optimizing software GeneOptimizer®, to systematically improve production efficiency of protein-based therapeutics and vaccines. This emphasizes again our exceptional position as development partner for the pharmaceutical industry as well as the innovative potential of synthetic genes for research", explained Prof. Dr. Ralf Wagner, CEO of GENEART AG.
New Cell-weighing Technique Helps Predict How Drugs Affect Cancer CellsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE